Advances in Dietary Nutrition Intervention on Metabolic Diseases

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Nutrition and Metabolism".

Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 3475

Special Issue Editor


E-Mail Website
Guest Editor
Xiangya School of Public Health, Central South University, Changsha 410078, China
Interests: prevention and treatment of nutritional-related metabolic diseases; physiological effects and mechanisms of phytochemicals

Special Issue Information

Dear Colleagues,

We would like to invite you to submit an original research or review article to a Special Issue entitled “Advances in Dietary Nutrition Intervention on Metabolic Diseases”.

Metabolic diseases, including obesity, diabetes, gout, etc., have caused a great burden of disease around the world. Poor nutritional status is highly correlated with the occurrence and progression of metabolic diseases. A lot of recent studies have shown that the prevention and control of metabolic diseases can be achieved through dietary nutritional interventions or using food-related plant active components. Compared with conventional medical therapies, dietary interventions have attracted more and more attention from the medical community because of their affordability, low health risk, relevance to daily life, and so on. Therefore, this Special Issue entitled “Advances in Dietary Nutrition Intervention on Metabolic Diseases”, focuses on the latest research progress of dietary nutrition interventions on metabolic diseases, including (but not limited to) the identification of novel dietary factors treating the metabolic diseases and their potential mechanisms, the evaluation, analysis and challenges of the dietary nutrition intervention patterns in the population, and so on. Both original articles and reviews related to the topic are welcome.

Prof. Dr. Hong Qin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolic disorders
  • glucose and lipid metabolism
  • insulin resistance
  • noncommunicable diseases
  • energy imbalance
  • nutrients
  • phytochemicals
  • plant active components

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

Jump to: Other

41 pages, 14139 KiB  
Review
Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
by Yansong Fu, Zhipeng Wang and Hong Qin
Metabolites 2024, 14(4), 218; https://doi.org/10.3390/metabo14040218 - 12 Apr 2024
Viewed by 507
Abstract
Metabolic-associated fatty liver disease (MAFLD), characterized primarily by hepatic steatosis, has become the most prevalent liver disease worldwide, affecting approximately two-fifths of the global population. The pathogenesis of MAFLD is extremely complex, and to date, there are no approved therapeutic drugs for clinical [...] Read more.
Metabolic-associated fatty liver disease (MAFLD), characterized primarily by hepatic steatosis, has become the most prevalent liver disease worldwide, affecting approximately two-fifths of the global population. The pathogenesis of MAFLD is extremely complex, and to date, there are no approved therapeutic drugs for clinical use. Considerable evidence indicates that various metabolic disorders play a pivotal role in the progression of MAFLD, including lipids, carbohydrates, amino acids, and micronutrients. In recent years, the medicinal properties of natural products have attracted widespread attention, and numerous studies have reported their efficacy in ameliorating metabolic disorders and subsequently alleviating MAFLD. This review aims to summarize the metabolic-associated pathological mechanisms of MAFLD, as well as the natural products that regulate metabolic pathways to alleviate MAFLD. Full article
(This article belongs to the Special Issue Advances in Dietary Nutrition Intervention on Metabolic Diseases)
Show Figures

Graphical abstract

Other

Jump to: Review

23 pages, 2274 KiB  
Systematic Review
Impact of the Level of Adherence to the DASH Diet on Blood Pressure: A Systematic Review and Meta-Analysis
by Xenophon Theodoridis, Areti Triantafyllou, Lydia Chrysoula, Fotios Mermigkas, Violeta Chroni, Konstantina Dipla, Eugenia Gkaliagkousi and Michail Chourdakis
Metabolites 2023, 13(8), 924; https://doi.org/10.3390/metabo13080924 - 07 Aug 2023
Cited by 1 | Viewed by 2413
Abstract
Introduction: the objective of our study was to systematically review the current literature and perform a meta-analysis to evaluate the effect of the level of adherence to the DASH diet on blood pressure. Methods: The identification of relevant studies, data extraction [...] Read more.
Introduction: the objective of our study was to systematically review the current literature and perform a meta-analysis to evaluate the effect of the level of adherence to the DASH diet on blood pressure. Methods: The identification of relevant studies, data extraction and critical appraisal of the included studies were performed independently by two reviewers. A random-effects model was employed to synthesize the available evidence using the standardized mean difference (SMD) as the appropriate effect size. Results: A total of 37 and 29 articles were included in the qualitative and quantitative analysis, respectively. The pooled effect for systolic blood pressure was SMD = −0.18 (95%CI: −0.32 to −0.04; I2 = 94%; PI: −0.93 to 0.57) and for diastolic blood pressure it was SMD = −0.13 (95%CI: −0.19 to −0.06; I2 = 94%; PI: −0.42 to 0.17). Conclusions: Our findings showed that greater adherence to the DASH diet has a beneficial effect on blood pressure compared to the lowest adherence. Increased compliance with DASH diet recommendations might also have a positive effect on cardiometabolic factors and overall health status. Future studies should aim to standardize the tools of adherence to the DASH diet and utilize rigorous study designs to establish a clearer understanding of the potential benefits of the level of adherence to the DASH diet in blood pressure management. Full article
(This article belongs to the Special Issue Advances in Dietary Nutrition Intervention on Metabolic Diseases)
Show Figures

Figure 1

Back to TopTop